Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	76.97	17.13	9.68
Graham Fair Price	-13.43	1.15	1.33
PEG	-94.96	-0.25	5.06
Price/Book	24.13	1.05	0.85
Price/Cash Flow	-41.92	22.13	38.11
Prices/Earnings	67.98	6.51	3.88
Price/Sales	36.46	1.75	1.29
Price/FCF	-41.92	22.13	38.11
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	-4.45	0.62	0.65
Operating Margin	-44.25	0.04	0.06
ROA	-26.57	0.03	0.04
ROE	0.05	0.04	-26.10
ROIC	0.03	0.02	-45.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.33	-0.25	35.05
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.17	-0.49	185.12
EPS QOQ	< 0.005	-0.26	3234.43
FCF QOQ	-0.49	1.15	135.47
Revenue QOQ	0.05	-0.08	71.73
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	119.73	122.70	2.48
Days Sales Outstanding (DSO)	24.95	24.25	-2.83
Inventory Turnover	0.75	0.73	-2.42
Debt/Capitalization	0.04	0.06	30.36
Quick Ratio	1.77	1.71	-3.56
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	1.20	1.21	0.70
Cash	0.22	0.23	3.01
Capex	-0.02	-0.02	-0.76
Free Cash Flow	0.03	0.06	115.24
Revenue	0.79	0.73	-8.40
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	3.33	3.33	0.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.91	-2.40	-25.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating